August 28, 2017 — Philips Healthcare and HeartFlow Inc.
FFR Technologies
-
-
The gold standard for assessing the hemodynamic significance of coronary lesions to determine if they should be revascularized or treated medically is fractional flow reserve (FFR).
-
MDBuyline analyst Tom Watson shares some of the most important trends in cardiac technology he saw at the 2017 American College of Cardiology (ACC) Scientific Sessions.
-
Justin Davies, MBBS, of Imperial College London, and Matthias Götberg, M.D, Ph.D., of Skane University Hospital, detail the positive results of the DEFINE-FLAIR and IFR-SWEDEHEART trials presented...
News | FFR Technologies | August 28, 2017
August 28, 2017 — Philips Healthcare and HeartFlow Inc. announced they entered into a collaboration agreement to...
News | FFR Technologies | August 09, 2017
August 9, 2017 — HeartFlow Inc. announced that four Blue Cross Blue Shield companies have each issued a positive...
Philips released a new version of its iFR system that displays hemodynamic pressure drop points in an overlay on live angiographic images, matching up the iFR readings with corresponding lesions. The system is supposed to speed diagnostic decision making and help guide percutaneous revascularization procedures.
Feature | FFR Technologies | July 31, 2017 | Dave Fornell
The gold standard for assessing the hemodynamic significance of coronary lesions to determine if they should be...
An example of an FFR-CT image, showing the FFR values for all coronary vessel segments and the reduction in hemodynamic flow after specific lesions.
News | CT Angiography (CTA) | July 12, 2017
July 12, 2017 — The American Medical Association (AMA) has granted a Category III Tracking Code for estimated...
HeartFlow FFR-CT can noninvasively assess the hemodynamic impact of coronary lesions to avoid the need for an invasive angiogram.
Technology | CT Angiography (CTA) | July 06, 2017
July 6, 2017 — GE Healthcare and HeartFlow Inc. announced at the annual scientific meeting of the Society of...
News | FFR Technologies | May 31, 2017
May 31, 2017 — Acist Medical Systems Inc. announced results from the ACIST-FFR Study demonstrating the consistent...
News | FFR Technologies | May 30, 2017
May 30, 2017 — Early results from the independent, physician-sponsored FFR-Search Registry revealed an association...
Videos | Cath Lab | March 28, 2017
MDBuyline analyst Tom Watson shares some of the most important trends in cardiac technology he saw at the 2017...
Feature | Cath Lab | March 27, 2017
March 27, 2017 — Patients experiencing a major heart attack often have more than one clogged artery, but under...
News | Cardiac Imaging | March 24, 2017
March 24, 2017 — At the 2017 American College of Cardiology's Annual Scientific Session & Expo (ACC.17), Philips...
Videos | FFR Technologies | March 23, 2017
Justin Davies, MBBS, of Imperial College London, and Matthias Götberg, M.D, Ph.D., of Skane University Hospital,...
Matthias Götberg, principal investigator for the iFR-SWEDEHEART study, and Justin E. Davies, lead investigator for the DEFINE-FLAIR trial, share key points of their study with DAIC editor Dave Fornell at ACC.17. The trials showed iFR is equal in outcomes to FFR in assessing coronary lesions.
Feature | FFR Technologies | March 20, 2017
March 20, 2017 — For patients experiencing angina (chest pain) or a heart attack, instantaneous wave-free ratio (iFR...
News | CT Angiography (CTA) | February 14, 2017
February 14, 2017 — The National Institute for Health and Care Excellence (NICE) in the United Kingdom recently...
News | FFR Technologies | January 12, 2017
January 12, 2017 — Acist Medical Systems Inc. announced that enrollment is complete for its...
Videos | TCT | November 18, 2016
DAIC Editor Dave Fornell takes a video tour of some of the most innovative new interventional cardiology...
